JP2021534089A - 細菌株を含む組成物 - Google Patents

細菌株を含む組成物 Download PDF

Info

Publication number
JP2021534089A
JP2021534089A JP2021505956A JP2021505956A JP2021534089A JP 2021534089 A JP2021534089 A JP 2021534089A JP 2021505956 A JP2021505956 A JP 2021505956A JP 2021505956 A JP2021505956 A JP 2021505956A JP 2021534089 A JP2021534089 A JP 2021534089A
Authority
JP
Japan
Prior art keywords
composition
cells
mrx0004
eps
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534089A5 (https=
Inventor
イムケ エリザベス ムルダー
マルシリオ アドリアニ
エイミー ベス ホルト
マリア クリストフィ
フィリップ コウィー
エマ ラフティス
デルフィン ルイーズ クローデット ラウテ−カリー
エマ エリザベス クレア ヘネシー
スアード アーメッド
アンナ エトール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
4D Pharma Research Ltd
Original Assignee
4D Pharma Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed by 4D Pharma Research Ltd filed Critical 4D Pharma Research Ltd
Publication of JP2021534089A publication Critical patent/JP2021534089A/ja
Publication of JP2021534089A5 publication Critical patent/JP2021534089A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2021505956A 2018-08-17 2019-08-19 細菌株を含む組成物 Pending JP2021534089A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
EP18189521.0 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817648.7 2018-10-29
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GB1900335.9 2019-01-10
GB1901203.8 2019-01-29
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
PCT/EP2019/072181 WO2020035623A1 (en) 2018-08-17 2019-08-19 Compositions comprising bacterial strains

Publications (2)

Publication Number Publication Date
JP2021534089A true JP2021534089A (ja) 2021-12-09
JP2021534089A5 JP2021534089A5 (https=) 2022-08-29

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505956A Pending JP2021534089A (ja) 2018-08-17 2019-08-19 細菌株を含む組成物

Country Status (14)

Country Link
US (1) US20210330786A1 (https=)
EP (1) EP3836945A1 (https=)
JP (1) JP2021534089A (https=)
KR (1) KR20210046007A (https=)
CN (1) CN113423413A (https=)
AU (1) AU2019322090A1 (https=)
BR (1) BR112021002917A2 (https=)
CA (1) CA3108235A1 (https=)
IL (1) IL280895A (https=)
MA (1) MA53228A (https=)
MX (1) MX2021001888A (https=)
SG (1) SG11202101580TA (https=)
TW (1) TW202023590A (https=)
WO (1) WO2020035623A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用
CN119144528B (zh) * 2024-11-20 2025-06-06 青岛诺和诺康生物科技有限公司 两歧双歧杆菌及其改善哮喘及组胺不耐受的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160143961A1 (en) * 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
JP2017515890A (ja) * 2014-04-10 2017-06-15 国立研究開発法人理化学研究所 Ｔｈ１７細胞の誘導のための組成物及び方法
JP2017533882A (ja) * 2015-06-15 2017-11-16 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 ｌｍｃ５２０ 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR102844378B1 (ko) 2016-05-31 2025-08-07 모리나가 뉴교 가부시키가이샤 뇌기능 개선제

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017515890A (ja) * 2014-04-10 2017-06-15 国立研究開発法人理化学研究所 Ｔｈ１７細胞の誘導のための組成物及び方法
US20160143961A1 (en) * 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
JP2017533882A (ja) * 2015-06-15 2017-11-16 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物

Also Published As

Publication number Publication date
CA3108235A1 (en) 2020-02-20
MA53228A (fr) 2021-11-24
KR20210046007A (ko) 2021-04-27
WO2020035623A1 (en) 2020-02-20
IL280895A (en) 2021-04-29
SG11202101580TA (en) 2021-03-30
TW202023590A (zh) 2020-07-01
CN113423413A (zh) 2021-09-21
BR112021002917A2 (pt) 2021-05-11
EP3836945A1 (en) 2021-06-23
AU2019322090A1 (en) 2021-04-15
MX2021001888A (es) 2021-07-16
US20210330786A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
JP7368433B2 (ja) 細菌株を含む組成物
US10987387B2 (en) Compositions comprising bacterial strain
US11058732B2 (en) Compositions comprising bacterial strains
US11419931B2 (en) Compositions comprising bacterial strains
US20210330786A1 (en) Compositions comprising bacterial strains
WO2024182434A2 (en) Compositions for modulating gut microflora populations, treatment of dysbiosis and disease prevention, and methods for making and using same
OA20494A (en) Compositions comprising bacterial strains
HK40027894B (en) Compositions comprising bacterial strains
HK40027894A (en) Compositions comprising bacterial strains
HK1258786A1 (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220819

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220819

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230425

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230508

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230522

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231205